Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Abacus Medicine

02 4CSL Behring

03 72F. Hoffmann-La Roche

04 3Genentech

05 8Roche Diagnostics GmbH

06 1Takeda Pharmaceutical

07 4Western Province Blood Transfusion Service

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1200mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

02

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 840mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

03

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Immunoglobulin

Brand Name : Privigen®

Dosage Form : Infusion Solution

Dosage Strength : 100mg/ml

Packaging :

Approval Date : 22-07-2020

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

04

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Immunoglobulin

Brand Name : Privigen®

Dosage Form : Infusion Solution

Dosage Strength : 100mg/ml

Packaging :

Approval Date : 22-07-2020

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

05

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Immunoglobulin

Brand Name : Privigen®

Dosage Form : Infusion Solution

Dosage Strength : 100mg/ml

Packaging :

Approval Date : 22-07-2020

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

06

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Immunoglobulin

Brand Name : Privigen®

Dosage Form : Infusion Solution

Dosage Strength : 100mg/ml

Packaging :

Approval Date : 22-07-2020

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

07

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1200mg

Packaging :

Approval Date : 21/09/2017

Application Number : 20160430000118

Regulatory Info : Approved

Registration Country : Sweden

blank

08

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Injectable Solution

Dosage Strength : 1875mg

Packaging :

Approval Date : 18/01/2024

Application Number : 20221116000072

Regulatory Info : Approved

Registration Country : Sweden

blank

09

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 840mg

Packaging :

Approval Date : 26/08/2019

Application Number : 20180914000090

Regulatory Info : Approved

Registration Country : Sweden

blank

10

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1200mg/20ml

Packaging :

Approval Date : 23/05/2017

Application Number : 66152

Regulatory Info : Allowed

Registration Country : Switzerland

blank

11

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 840mg/14ml

Packaging :

Approval Date : 23/05/2017

Application Number : 66152

Regulatory Info : Allowed

Registration Country : Switzerland

blank

12

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Atezolizumab

Brand Name : TECENTRIQ subcutaneous

Dosage Form : Injectable Solution

Dosage Strength : 1875mg/15ml

Packaging :

Approval Date : 05/08/2024

Application Number : 69262

Regulatory Info : Allowed

Registration Country : Switzerland

blank

13

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Atezolizumab

Brand Name : Tecentriq®

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1200mg/20ml

Packaging :

Approval Date : 27-02-2023

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

14

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Solution For Injection

Dosage Strength : 1875mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

15

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1200mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

16

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 840mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

17

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1200mg/20ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

18

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

ATEZOLIZUMAB

Brand Name : TECENTRIQ

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 1200MG/20ML

Packaging :

Approval Date :

Application Number : 761034

Regulatory Info :

Registration Country : USA

blank

19

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

ATEZOLIZUMAB

Brand Name : TECENTRIQ

Dosage Form : INJECTABLE; INJECTION

Dosage Strength : 1200MG/20ML

Packaging :

Approval Date :

Application Number : 761041

Regulatory Info :

Registration Country : USA

blank

20

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

ATEZOLIZUMAB AND HYALURONIDASE-TQJS

Brand Name : TECENTRIQ HYBREZA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 125MG;2000UNITS PER ML

Packaging :

Approval Date :

Application Number : 761347

Regulatory Info :

Registration Country : USA

blank